Showing results (71-80 of 98) with videos related to
Sort By:
Pageof 10
Blood|February 21, 2013
Isolation and functional characterization of human erythroblasts at distinct stages: implications for understanding of normal and disordered erythropoiesis in vivoJingping Hu, Jing Liu, Fumin Xue, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 8, 2012
Validation of a prognostic model and the impact of mutations in patients with lower-risk myelodysplastic syndromesRafael Bejar, Kristen E Stevenson, Bennett A Caughey, et al.The New England Journal of Medicine|October 6, 2006
Lenalidomide in the myelodysplastic syndrome with chromosome 5q deletionAlan List, Gordon Dewald, John Bennett, et al.Haematologica|March 6, 2016
Prospective international validation of the Quality of Life in Myelodysplasia Scale (QUALMS)Gregory A Abel, Fabio Efficace, Rena J Buckstein, et al.Blood|August 30, 2011
Coordinate loss of a microRNA and protein-coding gene cooperate in the pathogenesis of 5q- syndromeMadhu S Kumar, Anupama Narla, Atsushi Nonami, et al.British Journal of Haematology|February 19, 2002
Increased incidence of mitochondrial cytochrome c-oxidase gene mutations in patients with myelodysplastic syndromesPoluru L Reddy, Vilasini T Shetty, Diya Dutt, et al.Journal of Hematology & Oncology|May 15, 2009
Phase 1-2a multicenter dose-escalation study of ezatiostat hydrochloride liposomes for injection (Telintra, TLK199), a novel glutathione analog prodrug in patients with myelodysplastic syndromeAzra Raza, Naomi Galili, Natalie Callander, et al.Cancer|September 3, 2011
A phase 2 randomized multicenter study of 2 extended dosing schedules of oral ezatiostat in low to intermediate-1 risk myelodysplastic syndromeAzra Raza, Naomi Galili, Scott E Smith, et al.Blood Advances|June 16, 2018
Severely impaired terminal erythroid differentiation as an independent prognostic marker in myelodysplastic syndromesAbdullah Mahmood Ali, Yumin Huang, Ronald Feitosa Pinheiro, et al.Hematology (Amsterdam, Netherlands)|June 16, 2001
Pentoxifylline, Ciprofloxacin and Dexamethasone Improve the Ineffective Hematopoiesis in Myelodysplastic Syndrome Patients; MalignancyAzra Raza, Huma Qawi, Tanja Andric, et al.Pageof 10